XOMA Executives to Present at BIO2007 Convention, Rodman & Renshaw Global Healthcare, Needham Biotechnology and Jefferies Healthcare Conferences
May 07, 2007 18:30 ET
|
XOMA Corporation
BERKELEY, Calif., May 7, 2007 (PRIME NEWSWIRE) -- Executives from XOMA Ltd. (Nasdaq:XOMA), a therapeutic antibody discovery and product development company, will be presenting at four upcoming...
XOMA Announces May 10 Conference Call and Webcast Discussion of First Quarter 2007 Financial Results
April 26, 2007 19:01 ET
|
XOMA Corporation
BERKELEY, Calif., April 26, 2007 (PRIME NEWSWIRE) -- XOMA Ltd. (Nasdaq:XOMA) will issue a news release announcing its first quarter financial results for the quarter ended March 31, 2007 on Thursday,...
XOMA Announces Clinical Trial Plans for XOMA 052 in Type 2 Diabetes
April 12, 2007 09:00 ET
|
XOMA Corporation
BERKELEY, Calif., April 12, 2007 (PRIME NEWSWIRE) -- XOMA Ltd. (Nasdaq:XOMA) today announced plans to initiate clinical testing of XOMA 052, a potent anti-inflammatory monoclonal antibody targeting...
XOMA Reports 2006 Results
March 08, 2007 16:00 ET
|
XOMA Corporation
BERKELEY, Calif., March 8, 2007 (PRIME NEWSWIRE) -- XOMA Ltd. (Nasdaq:XOMA), a leader in the discovery and development of antibody therapeutics for cancer and immunological disorders, today announced...
XOMA Announces Automatic Conversion of All Remaining Outstanding Convertible Notes
March 07, 2007 09:05 ET
|
XOMA Corporation
BERKELEY, Calif., March 7, 2007 (PRIME NEWSWIRE) -- XOMA Ltd. (Nasdaq:XOMA) announced today that it has elected to automatically convert all of its remaining outstanding Convertible SNAPs(sm) due 2012...
XOMA Announces March 8 Conference Call and Webcast Discussion of Fourth Quarter and Full-Year 2006 Results
March 02, 2007 14:00 ET
|
XOMA Corporation
BERKELEY, Calif., March 2, 2007 (PRIME NEWSWIRE) -- XOMA Ltd. (Nasdaq:XOMA) will issue a news release announcing its fourth quarter and full-year 2006 financial results for the periods ended December...
XOMA and Takeda Expand Collaboration for Therapeutic Antibody Discovery and Development
February 28, 2007 03:07 ET
|
XOMA Corporation
BERKELEY, Calif. and OSAKA, Japan, Feb. 28, 2007 (PRIME NEWSWIRE) -- XOMA Ltd. (Nasdaq:XOMA) and Takeda Pharmaceutical Company Limited (TSE4502:Takeda) announced today they have amended their existing...
XOMA Announces Expiration of Oncology Exclusivity Obligation With Novartis
February 28, 2007 03:04 ET
|
XOMA Corporation
Expiration of the Oncology Exclusivity Term Expands XOMA's Independent
Partnering Opportunities for Therapeutic Antibody
Discovery and Development
BERKELEY,...
XOMA Announces Planned Retirement of Chief Executive Officer
February 26, 2007 13:00 ET
|
XOMA Corporation
BERKELEY, Calif., Feb. 26, 2007 (PRIME NEWSWIRE) -- Jack Castello, Chairman of the Board, President and Chief Executive Officer of XOMA Ltd. (Nasdaq:XOMA), announced today his plans to retire. Mr....
XOMA to Present At Two Investor Conferences in February
February 09, 2007 12:19 ET
|
XOMA Corporation
BERKELEY, Calif., Feb. 9, 2007 (PRIME NEWSWIRE) -- XOMA Ltd. (Nasdaq:XOMA) announced today that J. David Boyle II, XOMA's vice president of finance and chief financial officer, will present an...